title: Treatment of hypereosinophilic syndrome in a child using cyclosporine: implication for a primary T-cell abnormality.
authors.affiliation: Division of Immunology and Allergy, Hospital for Sick Children, Toronto, Ontario, Canada.
authors.forename: S
authors.initials: S
authors.lastname: Nadarajah
authors.forename: B
authors.initials: B
authors.lastname: Krafchik
authors.forename: C
authors.initials: C
authors.lastname: Roifman
authors.forename: C
authors.initials: C
authors.lastname: Horgan-Bell
mesh_terms: D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D002648:Child; D016572:Cyclosporine / Q000627:therapeutic use*; D003872:Dermatitis / Q000188:drug therapy / Q000209:etiology; D005260:Female; D006801:Humans; D017681:Hypereosinophilic Syndrome / Q000150:complications / Q000188:drug therapy*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D011241:Prednisone / Q000627:therapeutic use
chemical_list: D000893:Anti-Inflammatory Agents; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D011241:Prednisone